Littérature scientifique sur le sujet « Pancreatic cancer, Radiofrequency ablation, immunity »

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Pancreatic cancer, Radiofrequency ablation, immunity ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Pancreatic cancer, Radiofrequency ablation, immunity"

1

Jarosova, Jana, Peter Macinga, Lenka Krupickova, Martina Fialova, Alzbeta Hujova, Jan Mares, Ondrej Urban et al. « Impact of Endoluminal Radiofrequency Ablation on Immunity in Pancreatic Cancer and Cholangiocarcinoma ». Biomedicines 10, no 6 (6 juin 2022) : 1331. http://dx.doi.org/10.3390/biomedicines10061331.

Texte intégral
Résumé :
Radiofrequency ablation (RFA) is a mini-invasive loco-regional ablation technique that is increasingly being used as a palliative treatment for pancreatic cancer and cholangiocarcinoma. Ablation-triggered immune system stimulation has been proposed as a mechanism behind the systemic effects of RFA. The aim of our study was to investigate the immune response to endoluminal biliary RFA. Peripheral blood samples were collected from patients with pancreatic cancer and cholangiocarcinoma randomised to receive endoluminal biliary radiofrequency ablation + stent (19 patients) or stent only (21 patients). We observed an early increase in IL-6 levels and a delayed increase in CXCL1, CXCL5, and CXCL11 levels as well as an increase in CD8+ and NK cells. However, these changes were not specific to RFA treatment. Explicitly in response to RFA, we observed a delayed increase in serum CXCL1 levels and an early decrease in the number of anti-inflammatory CD206+ blood monocytes. Our study provides the first evidence of endoluminal biliary RFA-based regulation of the systemic immune response in patients with pancreatic cancer and cholangiocarcinoma. These changes were characterised by a general inflammatory response. RFA-specific activation of the adaptive immune system was not confirmed.
Styles APA, Harvard, Vancouver, ISO, etc.
2

Giardino, A., R. Girelli, I. Frigerio, P. Regi, F. Scopelliti, O. Perbellini, G. Innamorti, M. Bacchion, P. Pederzoli et C. Bassi. « Immunity stimulation after radiofrequency ablation of locally advanced pancreatic cancer : Preliminary results ». HPB 18 (avril 2016) : e760. http://dx.doi.org/10.1016/j.hpb.2016.01.265.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Hadjicostas, P., N. Malakounides, C. Varianos, E. Kitiris, F. Lerni et P. Symeonides. « Radiofrequency ablation in pancreatic cancer ». HPB 8, no 1 (février 2006) : 61–64. http://dx.doi.org/10.1080/13651820500466673.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Sarno, Alessandro, Alessandro Beleù, Riccardo De Robertis, Gabriele Giannotti, Giorgia Tedesco, Salvatore Paiella et Mirko D'Onofrio. « Radiofrequency Ablation of Pancreatic Cancer ». Digestive Disease Interventions 03, no 02 (10 mai 2019) : 133–37. http://dx.doi.org/10.1055/s-0039-1688437.

Texte intégral
Résumé :
AbstractRadiofrequency ablation (RFA) is emerging as a safe and feasible technique to treat various pancreatic lesions. In particular, pancreatic ductal adenocarcinoma (PDAC) is the most frequent treated lesion. Nowadays, PDAC treatment by means of RFA is limited to locally advanced, non-resectable, but non-metastatic lesions. The aim of this article is to describe the RFA technique, its results and possible complications.
Styles APA, Harvard, Vancouver, ISO, etc.
5

Hlavsa, J., V. Procházka, Z. Kala, T. Andrašina, B. Hemmelová, T. Pavlík, I. Penka et al. « Radiofrequency ablation of pancreatic cancer ». Pancreatology 12, no 6 (novembre 2012) : 586. http://dx.doi.org/10.1016/j.pan.2012.11.287.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Chen, Sheng-Yang, et Xiao-Yong Li. « Radiofrequency ablation for unresectable pancreatic cancer ». World Chinese Journal of Digestology 21, no 31 (2013) : 3383. http://dx.doi.org/10.11569/wcjd.v21.i31.3383.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Logue, Jennifer, Edward Leen, Susan J. Moug, Ross Carter et Colin McKay. « M1550 Radiofrequency Ablation of Locally Advanced Pancreatic Cancer ». Gastroenterology 134, no 4 (avril 2008) : A—871. http://dx.doi.org/10.1016/s0016-5085(08)64082-2.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Giardino, A., G. Innamorati, R. Girelli, I. Frigerio, P. Regi, F. Scopelliti, S. Paiella, P. Pederzoli, C. Bassi et G. Butturini. « Radiofrequency ablation of locally advanced pancreatic cancer : immunostimulation patterns ». HPB 21 (2019) : S977—S978. http://dx.doi.org/10.1016/j.hpb.2019.10.1287.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Giardino, A., G. Innamorati, R. Girelli, I. Frigerio, P. Regi, F. Scopelliti, S. Paiella, P. Pederzoli, C. Bassi et G. Butturini. « Radiofrequency ablation of Locally Advanced Pancreatic Cancer : Immunostimulation Patterns ». HPB 21 (2019) : S766. http://dx.doi.org/10.1016/j.hpb.2019.10.1523.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Zou, Yi-Ping. « Intraoperative radiofrequency ablation combined with125iodine seed implantation for unresectable pancreatic cancer ». World Journal of Gastroenterology 16, no 40 (2010) : 5104. http://dx.doi.org/10.3748/wjg.v16.i40.5104.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Chapitres de livres sur le sujet "Pancreatic cancer, Radiofrequency ablation, immunity"

1

Ji, Jiansong. « Radiofrequency and microwave ablation for pancreatic cancer ». Dans Integrative Pancreatic Intervention Therapy, 341–48. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-12-819402-7.00013-9.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Pancreatic cancer, Radiofrequency ablation, immunity"

1

« Clinical application of radiofrequency ablation in the treatment of unresectable pancreatic cancer ». Dans The 2nd World Conference on Humanities and Social Sciences. Francis Academic Press, 2018. http://dx.doi.org/10.25236/wchss.2017.02.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Biasutto, D., S. Stigliano, F. Covotta et FMD Matteo. « ENDOSCOPIC ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION OF PANCREATIC METASTASIS FROM RENAL CELL CANCER : FEASIBILITY AND SAFETY ». Dans ESGE Days. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1704984.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Hanks, Bradley, Mary Frecker et Matthew Moyer. « Optimization of a Compliant Endoscopic Radiofrequency Ablation Electrode ». Dans ASME 2017 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/detc2017-67357.

Texte intégral
Résumé :
Radiofrequency ablation (RFA) is a common cancer treatment modality for patients who are ineligible for open surgery. There is a need for RFA electrodes that generate heating zones that closely match the geometry of typical tumors, especially for endoscopic ultrasound-guided (EUS) RFA. In this paper, the procedure for optimization of an RFA electrode is presented. First, a novel compliant electrode design is proposed. Next, a thermal ablation model is developed to predict the ablation zone surrounding an RFA electrode in biological tissue. Then, a multi-objective genetic algorithm is used to optimize two cases of the electrode geometry to match the region of destructed tissue to a spherical tumor of specified diameter. This optimization procedure is applied to an EUS-RFA ablation of pancreatic tissue. For a target 2.5cm spherical tumor, the optimal design parameters of the compliant electrode design were found. After simulating 40 generations of 50 designs per generation, both cases converged to optimal solutions. The objective functions were useful for simple electrode designs. For more complex electrode designs, the objective functions were unable to direct the design toward a 2.5cm sphere. The results of the optimization demonstrate how computational models combined with optimization can be used for systematic design of ablation electrodes. The optimization procedure may be applied to RFA of various tissue types for systematic design of electrodes that generate spherical ablation zones.
Styles APA, Harvard, Vancouver, ISO, etc.
4

Hanks, Bradley W., Mary Frecker et Matthew Moyer. « Design of a Compliant Endoscopic Ultrasound-Guided Radiofrequency Ablation Probe ». Dans ASME 2016 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/detc2016-59923.

Texte intégral
Résumé :
Pancreatic cancer is one of the most deadly forms of cancer in the United States. Due to its late diagnosis, only 20% of patients diagnosed with the disease are eligible for surgical resection which is considered the preferred method of treatment. Radiofrequency ablation is a common cancer treatment modality for patients ineligible for open surgery. There is a lack of ablation probes which may be used to generate spherical heating zones which closely match the geometry of typical tumors. In particular, there are no endoscopic ablation probes commercially available in the United States. In this paper the design of a compliant endoscopic radiofrequency ablation probe is presented. This probe features an array of compliant tines which deploy through the cancerous tissue to effectively broaden the ablation zone. A thermal ablation model is used to inform the design of the geometry of the probe. In addition, finite element analysis is used to determine the feasibility of the compliant structures. These design tools are used as aids to inform the design and direct modifications toward a feasible probe which generates a spherical ablation zone.
Styles APA, Harvard, Vancouver, ISO, etc.
5

Tiankanon, Kasenee, Pradermchai Kongkam, Thanawat Luangsukrerk, Virote Sriuranpong, Chonnipa Nantavithya, Trirat Jantarattana, Arlyn Canones et al. « IDDF2019-ABS-0171 EUS-Guided radiofrequency ablation as adjunctive treatment for unresectable pancreatic cancer versus chemotherapy alone (ERAP) ». Dans International Digestive Disease Forum (IDDF) 2019, Hong Kong, 8–9 June 2019. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2019. http://dx.doi.org/10.1136/gutjnl-2019-iddfabstracts.179.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Tiankanon, K., P. Kongkam, T. Orprayoon, T. Luangsukrerk, DW Seo, V. Sriuranpong, C. Nantavithya et al. « EUS-GUIDED RADIOFREQUENCY ABLATION PLUS CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR UNRESECTABLE PANCREATIC CANCER (ERAP) : PRELIMINARY RESULTS OF A PROSPECTIVE COMPARATIVE STUDY ». Dans ESGE Days 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1681343.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!

Vers la bibliographie